Which of the following vitamin reduces the risk of insulin resistance, obesity, and the metabolic syndrome?
**Core Concept**
Vitamin D plays a critical role in glucose metabolism and insulin sensitivity. It regulates the expression of genes involved in insulin signaling and adipocyte function, and deficiency is strongly linked to increased risk of insulin resistance, obesity, and metabolic syndrome.
**Why the Correct Answer is Right**
Vitamin D enhances insulin sensitivity by modulating the activity of insulin receptor substrate-1 (IRS-1) and downstream PI3K/AKT signaling pathways. It also reduces adipose tissue inflammation and promotes fat metabolism. Epidemiological studies show that individuals with low serum 25-hydroxyvitamin D levels have higher risks of type 2 diabetes and metabolic syndrome. Additionally, vitamin D receptor (VDR) is expressed in pancreatic beta cells and skeletal muscle, key tissues in glucose homeostasis.
**Why Each Wrong Option is Incorrect**
Option A: Vitamin A does not directly influence insulin signaling or adipose metabolism. While it supports immune function, it lacks evidence linking it to improved insulin sensitivity.
Option B: Vitamin C is an antioxidant that may help reduce oxidative stress in diabetes but does not significantly improve insulin resistance or metabolic syndrome risk.
Option D: Vitamin B12 is essential for neurological and hematological health but has no direct role in glucose metabolism or metabolic syndrome prevention.
**Clinical Pearl / High-Yield Fact**
Low vitamin D levels are a modifiable risk factor for metabolic syndrome—correcting deficiency may improve insulin sensitivity, especially in overweight or obese patients. Routine screening and supplementation in at-risk groups (e.g., elderly, sedentary individuals) are recommended.
✓ Correct Answer: C. Vitamin D